-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Chromocell Therapeutics Corp quarterly/annual Operating Income (Loss) history and growth rate from Q1 2023 to Q3 2024.
- Chromocell Therapeutics Corp Operating Income (Loss) for the quarter ending September 30, 2024 was -$2.05M, a 58.6% decline year-over-year.
- Chromocell Therapeutics Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was -$9.63M.
- Chromocell Therapeutics Corp annual Operating Income (Loss) for 2023 was -$6.86M, a 196% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)